arrow_back Civic Audit
Share share

LymeX Act: $5 Million for Faster Lyme Disease Innovation and Care

This bill provides funding for prize competitions to speed up the development of new ways to prevent, diagnose, and treat Lyme disease. It aims to bring better tests and treatments to patients more quickly by encouraging innovation.
Key points
$5 million authorized for prizes to drive medical breakthroughs in Lyme disease.
Focus on creating faster, patient-centered diagnostic tests.
Encourages collaboration between government, business, and researchers to improve patient care.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_7482
Sponsor: Rep. Smith, Christopher H. [R-NJ-4]
Process start date: 2026-02-11
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

LymeX Authorization Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_7482.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2026-02-11.

What are the main provisions?

Key points include:

  • $5 million authorized for prizes to drive medical breakthroughs in Lyme disease.
  • Focus on creating faster, patient-centered diagnostic tests.
  • Encourages collaboration between government, business, and researchers to improve patient care.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Smith, Christopher H. [R-NJ-4].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-02-18.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health